• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconMylan

Mylan

Page 3 of 6
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
HealthMylan To Pay $465 Million Over EpiPen Medicaid Rebate Dispute
By ReutersOctober 7, 2016
Mylan CEO Heather Bresch Testifies On EpiPen Price Increases Before The House Oversight And Government Reform Committee
HealthGovernment Health Plans Spent Over $1 Billion on Mylan EpiPens Over 5 Years
By Fortune Editors and Reuters and Michelle TohOctober 6, 2016
money in pill bottles
CommentaryHere’s Another Threat To Affordable Drugs
By Gil GutknechtOctober 5, 2016
US-VOTE-DEMOCRATS-CLINTON
LeadershipHillary Is Expected to Go After These Companies in a Big Speech Monday
By Reuters and Michelle TohOctober 3, 2016
One analyst thinks Mylan's EpiPen price hike ties back to its executive incentive plans.
HealthAgency Says It ‘Expressly Advised’ Mylan that the EpiPen Was Misclassified
By Reuters and Michelle TohSeptember 29, 2016
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
HealthSenators Want Justice Department to Investigate Mylan EpiPen Status
By ReutersSeptember 28, 2016
House Oversight Committee Holds Hearing On Rising Price Of EpiPens With Mylan Inc. CEO Heather Bresch
CommentaryMylan’s EpiPen Pricing Crossed Ethical Boundaries
By Daniel KozarichSeptember 27, 2016
Mylan CEO Heather Bresch Testifies On EpiPen Price Increases Before The House Oversight And Government Reform Committee
Health3 Highly Dubious Claims Mylan’s CEO Made to Congress
By Sy MukherjeeSeptember 26, 2016
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
HealthMylan’s Blogger Recruits May Have Been ‘Buttered Up’ to Help Pass Bills
By Reuters and Michelle TohSeptember 23, 2016
Mylan Inc. Chief Executive Officer Heather Bresch Interview
HealthMylan’s CEO Tells Congress the EpiPen Price Hike Was ‘Fair’
By Sy MukherjeeSeptember 21, 2016
Mylan's stock is the lowest it's been in at least 30 years, as CEO Heather Bresch gets ready to testify over EpiPen price hike.
HealthMylan’s Stock Is the Lowest It’s Been in 30 Years
By ReutersSeptember 21, 2016
HealthSenate Republicans Want Probe of Mylan EpiPen Price Hikes and Rebates
By ReutersSeptember 21, 2016
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
HealthA Minnesota Doctor Is Trying Get a $50 EpiPen Alternative to Market
By Sy MukherjeeSeptember 15, 2016
US-HEALTH-DRUGS-CONSUMER-POLITICS-MYLAN
HealthMylan Reportedly Paid Its Executives More Than Bigger Rivals
By Tom Huddleston Jr.September 14, 2016
Key Speakers At The Bloomberg Year Ahead 2015 Conference
HealthMylan’s CEO Will Testify Over EpiPen Price Hike
By ReutersSeptember 14, 2016
1
  • 1
  • 2
  • 3
  • 4
  • 5
6
Most Popular
Success
After decades in the music industry, Pharrell Williams admits he never stops working: ‘If you do what you love everyday, you’ll get paid for free'An image of a popular article
By Emma BurleighFebruary 3, 2026
Politics
Peter Thiel warns the Antichrist and apocalypse are linked to the ‘end of modernity’ currently happening—and cites Greta Thunberg as a driving exampleAn image of a popular article
By Nick LichtenbergFebruary 4, 2026
Investing
Ray Dalio warns the world is ‘on the brink’ of a capital war of weaponizing money—and gold is the best way for people to protect themselvesAn image of a popular article
By Sasha RogelbergFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.